Showing results (1701-1710 of 2,232) with videos related to
Sort By:
Pageof 224
Journal of Molecular Medicine (Berlin, Germany)|January 29, 2017
Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathwaysFeng-Sheng Wang, Wei-Shiung Lian, Mel S Lee, et al.Frontiers in Cardiovascular Medicine|February 13, 2025
Therapeutic effect and potential mechanism of Fufang Danshen dripping pills for stable coronary heart disease: a randomized controlled trialLi-Qin Meng, Pei-Ying Huang, Qing-Min Li, et al.Journal of Cancer Research and Clinical Oncology|November 7, 2023
Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615Yifan Shan, Tingting Xia, Weijia Xie, et al.Journal of the American Chemical Society|February 16, 2024
Electrolyte Chemistry toward Ultrawide-Temperature (-25 to 75 °C) Sodium-Ion Batteries Achieved by Phosphorus/Silicon-Synergistic Interphase ManipulationHao-Jie Liang, Han-Hao Liu, Xin-Xin Zhao, et al.Journal of Global Oncology|November 3, 2017
Managing Pain in Patients With Cancer: The Chinese Good Pain Management ExperienceShi-Ying Yu, Jie-Jun Wang, Yu-Guang Huang, et al.Oncotargets and Therapy|December 26, 2018
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring <i>EGFR</i> mutations: subgroup analysis of the LUX-Lung 6 trialYi-Long Wu, Chong-Rui Xu, Cheng-Ping Hu, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|May 17, 2017
Oxygen-Deficient Titanium Dioxide Nanosheets as More Effective Polysulfide Reservoirs for Lithium-Sulfur BatteriesHan-Chi Wang, Chao-Ying Fan, Yan-Ping Zheng, et al.Biochemistry|May 18, 2005
Structural difference between group I and group II cobra cardiotoxins: X-ray, NMR, and CD analysis of the effect of cis-proline conformation on three-fingered toxinsTing-Shou Chen, Fong-Yu Chung, Siu-Cin Tjong, et al.European Journal of Cancer (Oxford, England : 1990)|May 28, 2011
CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphismQiang Nie, Xue-Ning Yang, She-Juan An, et al.Cancer Treatment and Research Communications|January 1, 2021
Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancerXue-Tao Li, Jia-Tao Zhang, Hong-Hong Yan, et al.Pageof 224